CYTEK BIOSCIENCES INC. - COMMON STOCK

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

02 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

30 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

20 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

19 ноя 2024 16:00:00 Источник Nasdaq GlobeNewswire

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

07 ноя 2024 16:00:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences Reports Third Quarter 2024 Financial Results

05 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

30 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

29 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

18 сен 2024 16:00:00 Источник Nasdaq GlobeNewswire

Cytek Announces Resignation of Chief Operating Officer Chris Williams

12 сен 2024 14:20:00 Источник Nasdaq GlobeNewswire

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

21 авг 2024 16:00:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

08 авг 2024 15:05:01 Источник Nasdaq GlobeNewswire

Cytek Biosciences Reports Second Quarter 2024 Financial Results

06 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

30 июл 2024 16:00:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

30 июл 2024 15:05:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program

06 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

30 май 2024 15:05:03 Источник Nasdaq GlobeNewswire

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

28 май 2024 16:30:00 Источник Nasdaq GlobeNewswire

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

20 май 2024 16:30:00 Источник Nasdaq GlobeNewswire

Cytek Biosciences Reports First Quarter 2024 Financial Results

08 май 2024 15:05:53 Источник Nasdaq GlobeNewswire